StonvexLoading…
StonvexStonvexStonvexCore line items from EQIX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $2.62B | $2.44B | $9.22B | $6.80B | $4.48B |
Operating Income | Not available | $577.00M | $1.85B | $1.43B | $952.00M |
Net Income | Not available | $415.00M | $1.35B | $1.08B | $711.00M |
EPS (Diluted) | $4.51 | $4.20 | $13.76 | $11.07 | $7.26 |
Total Assets | Not available | $40.90B | $40.14B | $38.06B | $38.85B |
Total Liabilities | Not available | $26.58B | $25.96B | $23.88B | $24.74B |
Cash & Equivalents | Not available | $1.36B | $1.73B | $2.08B | $3.66B |
Free Cash Flow OCF − CapEx | Not available | $-539.00M | $-400.00M | $-108.00M | $14.00M |
Shares Outstanding | Not available | 98.62M | 98.23M | 98.19M | 97.86M |